Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 3, 1996, Pages 290-292

  Midolo, P D ^a   Lambert, J R ^b   Turnidge, J ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b PENINSULA HEALTH   (Australia)

Author keywords

Eradication; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; METRONIDAZOLE;

ADULT; AGE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEX; TREATMENT FAILURE;

EID: 0029981650     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00078.x     Document Type: Article

References (16)

1. Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marshall BJ. Helicobacter pylori: Causal agent in peptic ulcer disease? J. Gastroenterol. Hepatol. 1991; 6: 103-40.
2. Parsonnet J, Friedman GD, Vandensteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-31.
3. Lambert JR, Lin SK, Schembri M, Nicholson L, Korman MG. Helicobacter pylori therapy randomized study of Denol/antibiotic combinations. Rev. Esp. Enferm. Dig. 1990; 78 (Suppl. 1): 115-16 (Abstract).
4. Logan RPH, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH. One week eradication regimen for Helicobacter pylori. Lancet 1991; 338: 249-52.
5. Glupczynski Y. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 1992; 11: 777-81.
6. Glupczynski Y, Burrette A, de Koster E et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7.
7. Graham DY, Lew GM, Malaty HM et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
8. Rautelin H, Seppala K, Renkonen O et al. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob. Agents Chemother. 1992; 36: 163-6.
9. Bell GD, Powell K, Burridge A et al. Experience with triple anti-Helicobacter pylori eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. 1992; 6: 427-35.
10. Borody TJ, Brandl S, Andrews P, Ostapowicz N, Jankiewicz E. High efficacy, low dose triple therapy (TT) for Helicobacter pylori (Hp). Gastroenterology 1993; 102: A44.
11. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing, Fourth Information Supplement. NCCLS Document M100-54, NCCLS, Villanova, Pennsylvania, 1992.
12. Midolo PD, Turnidge J, Lambert JR. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Am. J. Gastroenterol. 1994; 89: 1383 (Abstract).
13. Lin SK, Lambert JR, Schembri M et al. A comparison of diagnostic tests to determine Helicobacter pylori infection. J. Gastroenterol. Hepatol. 1992; 7: 203-9.
14. Xia HX, Daw MA, Sant S, Beattie S, Keane CT, O'Morain CA. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur. J. Gastroenterol. Hepatol. 1993; 5: 141-4.
15. Graham DY, Ramirez FC, Lew GM et al. Tetracycline, clarithromycin, bismuth: A new effective triple therapy for Helicobacter pylori eradication. Gastroenterology 1993; 104: A90.
16. Bayerdörffer E, Mannes GA, Sommer A et al. High dose omeprazole treatment combined with amoxycillin eradicates Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 1992; 4: 697-702.